Farnesyltransferase Inhibitors: Potential Role in the Treatment of Cancer

ISSN： 0012-6667

Source： Drugs, Vol.61, Iss.6, 2001-01, pp. : 723-732

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

PARP Inhibitors: Mechanism of Action and Their Potential Role in the Prevention and Treatment of Cancer

By Basu Bristi Sandhu Shahneen K. de Bono Johann S.

Drugs, Vol. 72, Iss. 12, 2012-08 ,pp. : 1579-1590

Adis International

Access to resources Recommend Favorite

Farnesyltransferase Inhibitors and Rapamycin in the Treatment of Multiple Myeloma

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 6, 2006-12 ,pp. : 449-453

Bentham Science Publishers

Access to resources Recommend Favorite

Potential role of UGT pharmacogenetics in cancer treatment and prevention: focus on tamoxifen and aromatase inhibitors

By Lazarus Philip Sun Dongxiao

Drug Metabolism Reviews, Vol. 42, Iss. 1, 2010-02 ,pp. : 182-194

Informa Healthcare

Access to resources Recommend Favorite

The potential role of insulin-like growth factor receptor inhibitors in the treatment of advanced non-small cell lung cancer

By Gridelli Cesare Rossi Antonio Bareschino Maria Anna Schettino Clorinda Sacco Paola Claudia Maione Paolo

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 5, 2010-05 ,pp. : 631-639

Informa Healthcare

Access to resources Recommend Favorite

Potential Role of PKC Inhibitors in the Treatment of Hematological Malignancies

Current Pharmaceutical Design, Vol. 14, Iss. 21, 2008-07 ,pp. : 2075-2084

Bentham Science Publishers

Access to resources Recommend Favorite